BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33402836)

  • 1. Bioinformatics Analysis of Key Genes and Pathways of Cervical Cancer.
    Chen H; Wang X; Jia H; Tao Y; Zhou H; Wang M; Wang X; Fang X
    Onco Targets Ther; 2020; 13():13275-13283. PubMed ID: 33402836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.
    Xue H; Sun Z; Wu W; Du D; Liao S
    Cancer Manag Res; 2021; 13():117-131. PubMed ID: 33447084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive bioinformatics analysis for the screening of hub genes and molecular docking of phytochemicals present in kitchen spices to inhibit CDK1 in cervical cancer.
    Vaghasia H; Sakaria S; Prajapati J; Saraf M; Rawal RM
    Comput Biol Med; 2022 Oct; 149():105994. PubMed ID: 36103746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCNA in Cervical Intraepithelial Neoplasia and Cervical Cancer: An Interaction Network Analysis of Differentially Expressed Genes.
    Giannos P; Kechagias KS; Bowden S; Tabassum N; Paraskevaidi M; Kyrgiou M
    Front Oncol; 2021; 11():779042. PubMed ID: 34900731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis.
    Tu S; Zhang H; Yang X; Wen W; Song K; Yu X; Qu X
    Cancer Biomark; 2021; 32(3):303-315. PubMed ID: 34151839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate biomarkers correlated with the diagnosis and prognosis of cervical cancer via integrated bioinformatics analysis.
    Dai F; Chen G; Wang Y; Zhang L; Long Y; Yuan M; Yang D; Liu S; Cheng Y; Zhang L
    Onco Targets Ther; 2019; 12():4517-4532. PubMed ID: 31354287
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of druggable hub genes and key pathways associated with cervical cancer by protein-protein interaction analysis: An in silico study.
    Asadzadeh A; Ghorbani N; Dastan K
    Int J Reprod Biomed; 2023 Oct; 21(10):809-818. PubMed ID: 38077941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Core Prognosis-Related Candidate Genes in Cervical Cancer via Integrated Bioinformatical Analysis.
    Wei J; Wang Y; Shi K; Wang Y
    Biomed Res Int; 2020; 2020():8959210. PubMed ID: 32258155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
    Yang HJ; Xue JM; Li J; Wan LH; Zhu YX
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer.
    Wang J; Zheng H; Han Y; Wang G; Li Y
    Int J Genomics; 2020; 2020():4535820. PubMed ID: 33381538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
    Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
    Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biomarkers of inflammation-associated immunity in cervical cancer.
    Zhao W; Li Q; Wen S; Li Y; Bai Y; Tian Z
    Front Oncol; 2024; 14():1351736. PubMed ID: 38532933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis.
    Xing X; Xia Q; Gong B; Shen Z; Zhang Y
    Front Genet; 2022; 13():855557. PubMed ID: 35368701
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis.
    Wu K; Yi Y; Liu F; Wu W; Chen Y; Zhang W
    Oncol Lett; 2018 Jul; 16(1):1003-1009. PubMed ID: 29963176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of critical genes associated with radiotherapy resistance in cervical cancer by bioinformatics.
    Zhang Z; Xiang K; Tan L; Du X; He H; Li D; Li L; Wen Q
    Front Oncol; 2022; 12():967386. PubMed ID: 35965520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression network analysis identified atypical chemokine receptor 1 (ACKR1) association with lymph node metastasis and prognosis in cervical cancer.
    Liu J; Li S; Lin L; Jiang Y; Wan Y; Zhou S; Cheng W
    Cancer Biomark; 2020; 27(2):213-223. PubMed ID: 32083574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma.
    Jiang P; Cao Y; Gao F; Sun W; Liu J; Ma Z; Xie M; Fu S
    BMC Cancer; 2021 Jun; 21(1):694. PubMed ID: 34116656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis identifies hub genes and pathways in nasopharyngeal carcinoma.
    Liu K; Kang M; Zhou Z; Qin W; Wang R
    Oncol Lett; 2019 Oct; 18(4):3637-3645. PubMed ID: 31516577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.